Evidence map›Paper›PMID 39973906›Full record

ReviewJAC-antimicrobial resistance2025

Antibiotic resistance in the Middle East and Southern Asia: a systematic review and meta-analysis.

Rachel Mathu, Elizabeth Diago-Navarro, Emily Lynch, Marie-Amélie Degail, Janet Ousley, Rupa Kanapathipillai, Justine Michel, Marc Gastellu-Etchegorry, Nada Malou

Abstract readReview
In one paragraph

Review in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Observational
  5. Article
  6. Carbapenem Resistance inMicroorganisms · 2025
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rachel MathuMédecins Sans Frontières, New York, USA.
Elizabeth Diago-NavarroMédecins Sans Frontières, New York, USA.
Emily LynchDepartment of Intervention Epidemiology and Training, Epicentre, Paris, France.
Marie-Amélie DegailDepartment of Intervention Epidemiology and Training, Epicentre, Paris, France.
Janet OusleyMédecins Sans Frontières, Paris, France.
Rupa KanapathipillaiMédecins Sans Frontières, Paris, France.
Justine MichelMédecins Sans Frontières, Paris, France.
Marc Gastellu-EtchegorryDepartment of Intervention Epidemiology and Training, Epicentre, Paris, France.
Nada MalouMédecins Sans Frontières, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Despite global surveillance efforts, antibiotic resistance (ABR) is difficult to address in low- and middle-income countries (LMICs). In the absence of country-wide ABR surveillance data, peer-reviewed literature is the next most significant source of publicly available ABR data. Médecins Sans Frontières conducted this review in hopes of using the pooled findings to inform treatment choices in the studied countries where sufficient local ABR data are unavailable. Methods: A systematic literature review reporting ABR rates for six infection sites in nine countries in the Middle East and Southern Asia was conducted. PubMed was used to identify literature published between January 2012 and August 2022. A meta-analysis of the included studies ( Results: This paper focuses on sepsis, burns and wound infections, specifically, with the largest number of papers describing data from Iran, Türkiye and Pakistan. High (>30%) resistance to recommended first-line antibiotics was found. Gram-negative resistance to ceftriaxone, aminoglycosides and carbapenems was high in burn-related infections; colistin resistance among Conclusions: High-quality data on ABR in LMIC settings remain difficult to obtain. While peer-reviewed literature is a source of publicly available ABR data, it is of inconsistent quality; the field also lacks agreed reporting standards, limiting the capacity to pool findings. Nonetheless, high resistance to first-line antibiotics underscores the need for improved localized surveillance and stewardship.

Identifiers

PMID39973906
PMCPMC11836886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.